3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.
出版信息
Ann Rheum Dis. 1995 Sep;54(9):757-78. doi: 10.1136/ard.54.9.757.
Abstract
摘要
相似文献
1
3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.第三届国际风湿病免疫疗法研讨会。1995年5月10日至14日，塞浦路斯。摘要
Ann Rheum Dis. 1995 Sep;54(9):757-78. doi: 10.1136/ard.54.9.757.
2
Fourth International Symposium on the Immunotherapy of the Rheumatic Diseases. 21-25 May 1997, Cyprus.
Ann Rheum Dis. 1998 Mar;57(3):1779.
3
2nd International Symposium on the Immunotherapy of the Rheumatic Diseases. Proceedings. Brighton, England, April 1-4, 1993.第二届国际风湿病免疫治疗研讨会。会议论文集。英国布莱顿，1993年4月1日至4日。
Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S1-195.
4
5
5th International Symposium for Health Professionals in Rheumatology. Lillehammer, Norway, 28-31 May 1994. Abstracts.
Scand J Rheumatol Suppl. 1994;97:1-148.
6
Using immunotherapy to treat rheumatic diseases.使用免疫疗法治疗风湿性疾病。
Trends Immunol. 2002 Aug;23(8):383-4. doi: 10.1016/s1471-4906(02)02275-5.
7
Immunotherapy in rheumatic disease: an idea whose time has come--or gone?风湿性疾病中的免疫疗法：一个时机已至——或已逝的想法？
Immunol Today. 1996 Jan;17(1):9-12. doi: 10.1016/0167-5699(96)80561-5.
8
T cell epitope-specific immune therapy for rheumatic diseases.用于治疗风湿性疾病的T细胞表位特异性免疫疗法。
Arthritis Rheum. 2006 Jan;54(1):19-25. doi: 10.1002/art.21520.
9
[Extracorporeal immunotherapy of rheumatic diseases].
Vutr Boles. 1988;27(5):74-9.
10
Immunotherapy of rheumatic diseases--practice and prospects.风湿性疾病的免疫疗法——实践与展望
Immunol Today. 1991 Jun;12(6):177-9. doi: 10.1016/0167-5699(91)90048-X.
本文引用的文献
1
Therapeutic potential of protein kinase C inhibitors.蛋白激酶C抑制剂的治疗潜力。
Agents Actions. 1993 Jan;38(1-2):135-47. doi: 10.1007/BF02027225.
2
Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events.T细胞受体拮抗作用对T细胞与抗原呈递细胞之间相互作用以及T细胞信号转导事件的影响。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2671-5. doi: 10.1073/pnas.90.7.2671.
3
The role of interleukin-1 in disease.白细胞介素-1在疾病中的作用。
N Engl J Med. 1993 Jan 14;328(2):106-13. doi: 10.1056/NEJM199301143280207.
4
Metalloproteinase inhibitors as therapeutics.金属蛋白酶抑制剂作为治疗药物。
Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S91-4.
5
Soluble tumor necrosis factor receptors in human inflammatory synovial fluids.人类炎性滑液中的可溶性肿瘤坏死因子受体
Arthritis Rheum. 1993 Apr;36(4):485-9. doi: 10.1002/art.1780360408.
6
Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis.
Br J Rheumatol. 1993 Jul;32(7):589-94. doi: 10.1093/rheumatology/32.7.589.
7
Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen.
Eur J Immunol. 1993 Jul;23(7):1588-94. doi: 10.1002/eji.1830230729.
8
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.用抗白细胞介素-1治疗改善已建立的小鼠胶原诱导性关节炎。
Clin Exp Immunol. 1994 Feb;95(2):237-43. doi: 10.1111/j.1365-2249.1994.tb06517.x.
9
Tumour necrosis factor: a specific trigger in arthritis.
Res Immunol. 1993 Jun;144(5):342-7. doi: 10.1016/s0923-2494(93)80078-d.
10
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.用抗肿瘤坏死因子α嵌合单克隆抗体治疗类风湿性关节炎。
Arthritis Rheum. 1993 Dec;36(12):1681-90. doi: 10.1002/art.1780361206.
Zotero 插件